Ustekinumab Dosing Individualization in Crohn’s Disease Guided by a Population Pharmacokinetic–Pharmacodynamic Model

Ustekinumab is a monoclonal antibody used in Crohn’s disease (CD). Dose optimization in case of non-response and the role of pharmacokinetic–pharmacodynamic (PK-PD) monitoring remain unresolved dilemmas in clinical practice. We aimed to develop a population PK-PD model for ustekinumab in CD and simu...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar Zdovc, Jurij, Hanžel, Jurij, Kurent, Tina, Sever, Nejc, Koželj, Matic, Smrekar, Nataša, Novak, Gregor, Štabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, Tomaž, Ostanek, Barbara, Drobne, David, Grabnar, Iztok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538292/
https://www.ncbi.nlm.nih.gov/pubmed/34683880
http://dx.doi.org/10.3390/pharmaceutics13101587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538292/
https://www.ncbi.nlm.nih.gov/pubmed/34683880
http://dx.doi.org/10.3390/pharmaceutics13101587

Ejemplares similares